https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/accounts-receivable-net https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/accrued-advertising-current https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/accrued-insurance-current https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/accrued-marketing-costs-current https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/asset-impairment-charges https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/available-for-sale-gross-unrealized-gains https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/available-for-sale-gross-unrealized-loss https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/commercial-paper https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/cost-of-revenue https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/cost-of-revenue-2 https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/debt-carrying-amount https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/debt-face-amount https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/debt-issued https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/debt-maturing-in-rolling-after-year-five https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/debt-repaid https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/deferred-compensation-arrangement-with-individual-cash-award-granted-amount https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/deferred-compensation-arrangement-with-individual-cash-awards-granted-percentage https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/deferred-compensation-arrangement-with-individual-compensation-expense https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/deferred-finance-costs-gross https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/employee-stock-ownership-plan-esop-weighted-average-purchase-price-of-shares-purchased https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/entity-listing-par-value-per-share https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/gross-profit https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/income-loss-attributable-to-parent https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/income-tax-examination-penalties-and-interest-expense https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/income-tax-expense-benefit-adjustment-of-deferred-tax-asset-liability https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/increase-decrease-in-deferred-leasing-fees https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/increase-decrease-in-deferred-liabilities https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/interest-income-other https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/interest-payable-current https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/investments https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/investments-fair-value-disclosure https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/letters-of-credit-outstanding-amount https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/liabilities-other-than-longterm-debt-noncurrent https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/long-term-debt-and-capital-lease-obligations-current https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/long-term-debt-and-capital-lease-obligations-maturities-repayments-of-principal-after-year-five https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/long-term-debt-and-capital-lease-obligations-maturities-repayments-of-principal-in-year-five https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/long-term-debt-and-capital-lease-obligations-maturities-repayments-of-principal-in-year-four https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/long-term-debt-and-capital-lease-obligations-maturities-repayments-of-principal-in-year-three https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/long-term-debt-and-capital-lease-obligations-maturities-repayments-of-principal-in-year-two https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/long-term-debt-and-capital-lease-obligations-maturities-repayments-of-principal-remainder-of-fiscal-year https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/long-term-investments https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-before-tax https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/other-current-liabilities https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/other-expenses https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/other-receivables https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/other-tax-expense-benefit https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/paid-in-capital-share-based-compensation-and-exercise-of-stock-options https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/paid-in-capital-share-based-compensation-employee-stock-purchase-program-requisite-service-period-recognition https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/payments-for-restructuring https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/prepaid-expense-current https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/proceeds-from-issuance-of-preferred-stock-preference-stock-and-warrants https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/proceeds-from-sale-maturity-and-collections-of-investments https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/repayments-of-secured-debt https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/restructuring-and-related-cost-expected-cost https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/restructuring-charges https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/restructuring-reserve-current https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-comment-letters-drsltr https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-filings-15-12b https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-filings-425 https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-filings-cert https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-filings-defm14a https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/secondary-offerings-form-305b2 https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/secondary-offerings-form-drs https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/secondary-offerings-form-s-1mef https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/shares-issued-shares-employee-stock-ownership-plan https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/shares-paid-for-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/short-term-investments https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-award-shares-issued-in-period https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-options-nonvested-options-forfeited-number-of-shares https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/tax-rate-reconciliation-deductions https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-amount https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/utb-change https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/utb-decrease-from-current-year-positions https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/xeris-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted